This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesdaybenzinga_article·Aug 26 at 08:15 AMEVMN-4.31%TEAM+1.97%
Evommune (NYSE:EVMN) Price Target Cut to $29.00 by Analysts at Royal Bank Of CanadaMarket Beat·Aug 7 at 02:30 PMEVMN-4.31%
Evommune posts corporate presentation outlining Phase 2 inflammation-drug pipeline focusing on EVO756, EVO301PUBT·Aug 6 at 05:11 PMEVMN-4.31%
Evommune begins Phase IIb trial of EVO756 for migraineWorldPharmaceuticals·Jul 31 at 05:13 AMEVMN-4.31%
Evommune, Inc. $EVMN Stake Lessened by Octagon Capital Advisors LPMarket Beat·Jul 27 at 04:53 AMEVMN-4.31%
